Global Vaccine CDMO Market Report Segmented by Vaccine Type (mRNA, Viral Vector, Recombinant Protein, DNA Vaccine), Phase (Pre-clinical, Clinical, Commercial), End User (Biopharmaceutical & Vaccine Developers) Forecasts to 2030

Global Vaccine CDMO Market Segmentation

This report by Medi-Tech Insights provides the size of the global vaccine CDMO market at the regional- and country-level from 2023 to 2030. The report further segments the market based on vaccine type, phase, end user.

Market Size & Forecast (2023-2030), By Vaccine Type, USD Million

• mRNA Vaccines
• Viral Vector Vaccines
• Recombinant Protein Vaccines
• Inactivated & Live-Attenuated Vaccines
• Conjugate & Toxoid Vaccines
• DNA Vaccines
• Others

Market Size & Forecast (2023-2030), By Phase, USD Million

• Pre-clinical
• Clinical
• Commercial

Market Size & Forecast (2023-2030), By End User, USD Million

• Biopharmaceutical & Vaccine Developers Government & Public Health Agencies
• Others

Market Size & Forecast (2023-2030), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa